By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Uganda Cuts Cholera-Endemic Districts From 36 to Six Through Mass Vaccination Campaign
New StudiesResearch Digest

Uganda Cuts Cholera-Endemic Districts From 36 to Six Through Mass Vaccination Campaign

GMJ
Last updated: 31/05/2026 01:16
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|575 words

Uganda has dramatically reduced cholera transmission across its territory, cutting the number of endemic districts from 36 to six through systematic oral cholera vaccine campaigns between 2018 and 2021. The achievement represents a significant milestone for a country that has battled endemic cholera since 1971, according to new research published in PLOS Global Public Health.

94%
administrative coverage achieved in first round of Uganda’s oral cholera vaccination campaigns

Uganda’s cholera vaccination campaign reach

People targeted and coverage rates across 16 campaigns, 2018-2021

2.26m
people targeted
for vaccination
94%
first round
coverage
84%
second round
coverage

Source: Uganda Ministry of Health, 2024 | Georgian Medical Journal News

Mass vaccination drives cholera elimination

The research team, led by Dr. Godfrey Bwire from Uganda’s Ministry of Health, analyzed cholera surveillance data from 2018 to 2024 to assess the impact of 16 oral cholera vaccine (OCV) campaigns conducted in high-risk districts. Each campaign involved two vaccination rounds targeting populations in cholera hotspot subcounties.

Submit Your Paper
GMJ_Submit_Banner

Administrative coverage reached 94% for first rounds and 84% for second rounds across the 2.26 million people targeted, according to the World Health Organization-supported campaigns. The vaccination strategy focused on districts with the highest cholera burden based on historical surveillance data.

Enhanced surveillance detects cross-border transmission

Uganda complemented vaccination efforts with enhanced cholera surveillance, particularly in border areas where cross-border transmission poses ongoing risks. Since 2021, all cholera outbreaks in Uganda have been epidemiologically linked to cross-border spread from neighboring countries in the East African Community, highlighting the regional nature of cholera control challenges.

The country maintained its policy of administering single-dose doxycycline to all cholera patients and their immediate households, a strategy designed to treat infections and prevent outbreak spread. This approach aligns with CDC treatment guidelines for cholera case management.

Regional cooperation essential for elimination

The study’s findings underscore the importance of regional coordination in cholera elimination efforts. While Uganda achieved substantial reductions in endemic transmission, the persistence of cross-border cases demonstrates that lasting elimination requires coordinated action across the East African region.

Dr. Bwire and colleagues used the cholera elimination scorecard methodology to classify districts as endemic, eliminated, or relapsed based on surveillance data. This standardized approach allows for consistent monitoring of elimination progress across different geographic areas.

The number of endemic districts in Uganda fell from 36 prior to the vaccination campaigns to six after the campaigns, representing an 83% reduction in cholera-endemic areas.

— Dr. Godfrey Bwire, Uganda Ministry of Health (PLOS Global Public Health, 2024)

Key takeaways

  • Uganda reduced cholera-endemic districts by 83% through systematic OCV campaigns targeting 2.26 million people
  • Administrative vaccine coverage reached 94% in first rounds and 84% in second rounds across 16 campaigns
  • All cholera outbreaks since 2021 have been linked to cross-border transmission from neighboring countries

Frequently asked questions

How effective are oral cholera vaccines in preventing outbreaks?

Oral cholera vaccines provide 60-85% protection against cholera for 2-3 years when administered in two doses. Uganda’s campaigns achieved high coverage rates that contributed to substantial reductions in endemic transmission.

Why does cholera persist despite vaccination efforts?

Cross-border transmission from neighboring endemic countries continues to seed outbreaks in previously eliminated areas. Regional coordination is essential for sustained elimination.

What role does antibiotic treatment play in cholera control?

Single-dose doxycycline treatment for patients and household contacts helps reduce transmission by decreasing bacterial shedding duration and preventing secondary cases within families.

Uganda’s experience demonstrates that systematic vaccination campaigns combined with enhanced surveillance can achieve substantial reductions in cholera endemicity. However, sustaining these gains will require continued regional cooperation and cross-border disease surveillance to address the persistent threat of imported cases from neighboring endemic areas.

Source: Uganda’s cholera elimination journey in a cholera endemic region of Africa

Was this article helpful?

Related Coverage

TB-Related Stigma Remains Major Barrier to Treatment in Kenya, National Survey FindsJul 11, 2026
Atopic dermatitis affects 1 in 10 globally: what dermatologists and patients need to knowJul 11, 2026
Chronic Graft-versus-Host Disease: Early Detection and Management After Bone Marrow TransplantJul 11, 2026
Chronic graft-versus-host disease: diagnosis and management emerge as priority in transplant careJul 10, 2026
Related reference
  • Doxycycline · Drug
TAGGED:choleradisease eliminationpublic healthUgandavaccination
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
TB-Related Stigma Remains Major Barrier to Treatment in Kenya, National Survey Finds

A national survey of 357 TB patients across 11 Kenyan counties finds…

Atopic dermatitis affects 1 in 10 globally: what dermatologists and patients need to know

Atopic dermatitis affects approximately 1 in 10 people globally, making it the…

Chronic Graft-versus-Host Disease: Early Detection and Management After Bone Marrow Transplant

Chronic graft-versus-host disease affects 30–50% of bone marrow transplant recipients and requires…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Clinical UpdatesNew StudiesPracticeResearch Digest

BMJ Review: Acceptance and Inclusion Key to Supporting Autistic Children’s Development

By
Prof. Giorgi Pkhakadze
11/06/2026
Global HealthPolicy & Systems

WHO Declares International Emergency as Ebola Outbreak Spreads from Congo to Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Global HealthPolicy & Systems

WHO Declares International Emergency as Ebola Crosses DRC-Uganda Border

By
Prof. Giorgi Pkhakadze
31/05/2026
Global HealthPolicy & Systems

WHO Declares Emergency as Ebola Outbreak Spreads from DRC to Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up